Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammation and Threat Sensitivity in PTSD
NCT03048929Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2019
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Neural activity to threat as assessed with functional magnetic resonance imaging at 2 weeks. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT03048929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048929.